[Immunological aspects of inflammatory granulomas (author's transl)].
D000936:Antigen-Antibody Complex; D001402:B-Lymphocytes / Q000276:immunology; D002199:Capillary Permeability; D002464:Cell Migration Inhibition; D002634:Chemotaxis, Leukocyte; D004804:Eosinophils / Q000276:immunology; D006099:Granuloma / Q000276:immunology*; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000276:immunology; D007249:Inflammation; D008213:Lymphocyte Activation; D008264:Macrophages / Q000276:immunology; D009000:Monocytes / Q000276:immunology; D009113:Muramidase / Q000378:metabolism; D009243:NAD / Q000378:metabolism; D009249:NADP / Q000378:metabolism; D009336:Necrosis; D009504:Neutrophils / Q000276:immunology; D009895:Opsonin Proteins; D010586:Phagocytes / Q000201:enzymology; D010587:Phagocytosis; D013601:T-Lymphocytes / Q000276:immunology
D000936:Antigen-Antibody Complex; D009895:Opsonin Proteins; D009243:NAD; D009249:NADP; D009113:Muramidase
Les aspects immunologiques des granulomes inflammatoires